At a glance
- Originator Wyeth
- Class Anti-inflammatories; Antirheumatics
- Mechanism of Action Collagenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Osteoarthritis
Most Recent Events
- 13 Oct 2000 Profile reviewed but no significant changes made
- 09 Mar 1999 No-Development-Reported for Osteoarthritis in USA (Unknown route)
- 29 Aug 1996 New profile